Physician

Valentine U Otuechere, MD., MPH.

According to 2025 Medicare claims, Valentine Otuechere, MD., MPH. (NPI: 1508896275) practices family practice in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is CRESTPOINT MEDICAL GROUP INC (NPI: 1184458408) and primary practice location at 92878-9998.

Otuechere's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 496 traditional Medicare patients, billed 2,385 HCPCS/CPT codes, and received $203,724 in Medicare payments. The top billing code was 99345 (Residence visit for new patient with high level of medical decision making, per day, if using time, at least 75 minutes). Part D data shows 7,373 prescription claims across 324 beneficiaries totaling $563,453 in drug costs, led by Trulicity (Dulaglutide). DME data shows 13 claims. Open Payments data shows 18 records totaling $554. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $7,387 and ending at $203,724. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $124,405 to $563,453. In contrast, DME billing represents a smaller volume and rose steadily, from $588 to $1,928.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	53	163	$7,387
2016	66	268	$15,562
2017	54	202	$11,965
2018	59	227	$11,089
2019	49	178	$9,396
2020	39	97	$4,930
2021	46	93	$6,936
2022	59	147	$9,574
2023	43	89	$5,074
2024	496	2,385	$203,724

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	157	2,401	$124,405
2016	175	2,838	$172,544
2017	181	2,899	$211,887
2018	189	2,697	$166,261
2019	177	3,095	$160,644
2020	204	4,021	$204,167
2021	249	4,577	$304,296
2022	253	5,391	$393,822
2023	336	6,465	$583,012
2024	324	7,373	$563,453

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	27	$2,338
2017	12	35	$284
2018	N/R	12	$125
2019	N/R	25	$237
2020	N/R	27	$502
2021	N/R	28	$399
2022	N/R	63	$3,190
2023	N/R	52	$3,510
2024	N/R	13	$86

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99345	Residence visit for new patient with high level of medical decision making, per day, if using time, at least 75 minutes	441	441	$159
G0181	Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow	195	302	$85
99497	Advance care planning, first 30 minutes	466	557	$65
G0180	Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and	211	212	$44
G0318	Prolonged home or residence evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualif	424	472	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trulicity	Dulaglutide	175	4,913	$163,825
Januvia	Sitagliptin Phosphate	56	2,720	$49,144
Eliquis	Apixaban	44	2,130	$39,473
Jardiance	Empagliflozin	49	1,590	$30,413
Ozempic	Semaglutide	30	994	$27,857

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	N	N/R	13	$86

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$554	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Valentine U. Otuechere, MD., MPH.?

Tedicare shows public-source Medicare data for Valentine U. Otuechere, MD., MPH. (NPI 1508896275), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Valentine U. Otuechere, MD., MPH. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Valentine U. Otuechere, MD., MPH.?

Valentine U. Otuechere, MD., MPH. is linked to CRESTPOINT MEDICAL GROUP INC (billing NPI 1184458408) in the available physician profile data.

Does Valentine U. Otuechere, MD., MPH. have Open Payments data?

Valentine U. Otuechere, MD., MPH. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.